However, loss-of-function variants in NOX2 complex components that decrease or abrogate superoxide generation induce hyperinflammation in chronic granulomatous disease (CGD) patients with 40–50% of patients developing CGD-IBD over time [39,40]. The gene discussed is CYBB; the disease is inflammatory bowel disease.